Cytiva is a global life sciences company, part of Danaher, that supplies technologies, consumables, and services used to discover, develop, and manufacture biopharmaceuticals. Created in 2020 from the former GE Healthcare Life Sciences biopharma business, it supports customers from early research through clinical development and commercial production.
The company’s portfolio includes chromatography resins and systems, filtration and purification solutions, single‑use bioprocess equipment (such as bioreactors, mixers, and fluid management components), cell culture media and related hardware, as well as process analytics and automation software. Cytiva serves pharmaceutical and biotechnology companies, contract development and manufacturing organizations, and academic and government laboratories, with an emphasis on scalable and compliant bioprocessing.